Theratechnologies establishes new at-the-market facility

Theratechnologies establishes new at-the-market facility
  TORONTO – Theratechnologies Inc. (TSX-TH, NASDAQ-THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it has established an at-the-market equity program allowing Theratechnologies to issue and sell up to US $50 million common shares from treasury to the public at the Company’s sole discretion and at the prevailing market price. Sales of... Read More

CHAR announces California green hydrogen project

CHAR announces California green hydrogen project
TORONTO – CHAR Technologies Ltd. (TSXV: YES) announced a test project with Hitachi Zosen Inova (HZI) to develop a high-temperature pyrolysis to green hydrogen system at their existing San Luis Obispo anaerobic digestion facility in California. Under the definitive agreement with HZI’s SLO operating company, CHAR’s high-temperature pyrolysis system will process 18,000 tonnes per year of solid anaerobic digestate into... Read More

Field Trip obtains conditional approval to list on NASDAQ, symbol ‘FTRP’

Field Trip obtains conditional approval to list on NASDAQ, symbol ‘FTRP’
  TORONTO – Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF), a global leader in the development and delivery of psychedelic therapies, announced today that it has received conditional approval from The NASDAQ Stock Market LLC list its issued and outstanding common shares on the NASDAQ Global Select Market. Final approval of the listing is subject to the Company... Read More